Combination antiretroviral therapy in population affected by conflict: outcomes from large cohort in northern Uganda
Open Access
- 17 February 2009
- Vol. 338 (feb17 1), b201
- https://doi.org/10.1136/bmj.b201
Abstract
Objective To measure the clinical and immunological outcomes of HIV positive adult patients receiving combination antiretroviral therapy in conflict affected northern Uganda.Design Prospective cohort study.Setting Gulu District, northern Uganda.Participants 1625 adults (aged over 14 years) receiving combination antiretroviral therapy.Main outcome measures Primary outcome: all cause mortality. Secondary outcomes: impact of covariates (sex, age, CD4 count at start, adherence, tuberculosis at start, duration of treatment, and internally displaced person status) on mortality.Results Sixty nine (4.2%) patients died during follow-up. The mortality incidence rate was 3.48 (95% confidence interval 2.66 to 4.31) per 100 person years. Patients started treatment with a median CD4 count of 157 (interquartile range 90-220) cells/μl; most (1009; 63%) had World Health Organization stage 2 defined illness. Sixty two patients had pulmonary tuberculosis at the start of treatment. Of the 1521 patients with adherence data, 118 (7.8%) had adherence of less than 95% and 1403 (92.2%) had adherence of 95% or above.Conclusion Patients receiving combination antiretroviral therapy in conflict affected northern Uganda had a mortality comparable to that of patients in peaceful, low income settings and better adherence than patients in higher income settings. These favourable findings highlight the need to expand access to combination antiretroviral therapy in populations affected by armed conflict.Keywords
This publication has 15 references indexed in Scilit:
- Geographical information system and access to HIV testing, treatment and prevention of mother-to-child transmission in conflict affected Northern UgandaConflict and Health, 2007
- Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, UgandaAIDS, 2007
- Prevalence of HIV infection in conflict-affected and displaced people in seven sub-Saharan African countries: a systematic reviewThe Lancet, 2007
- HIV Treatment in a Conflict Setting: Outcomes and Experiences from Bukavu, Democratic Republic of the CongoPLoS Medicine, 2007
- Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, UgandaAIDS, 2007
- HIV-1 prevalence and factors associated with infection in the conflict-affected region of North UgandaConflict and Health, 2007
- Conflict and health: a paradigm shift in global health and human rightsConflict and Health, 2007
- Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesThe Lancet, 2006
- Response to Antiretroviral Therapy in HIV-Infected Patients Attending a Public, Urban Clinic in Kampala, UgandaClinical Infectious Diseases, 2006
- HIV/AIDS among Conflict‐affected and Displaced Populations: Dispelling Myths and Taking ActionDisasters, 2004